Mereo BioPharma Group Plc (MREO)
0.291
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.291
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 14.01% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -- |
| BioNTech SE | -169.3% |
| Silence Therapeutics Plc | -- |
| Autolus Therapeutics Plc | 55.20% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.61% |
| Return on Assets | -59.05% |
| Return on Invested Capital | -67.87% |
| Return on Net Operating Assets | -1.17K% |